Hematoschizotropic Drugs

Hematoschizotropic drugs are drugs that have a specific effect on hematopoietic cells, accelerating their division and differentiation. Such drugs are used in the treatment of various diseases associated with impaired formation or functioning of blood cells, such as anemia, leukemia, thrombocytopenia and others.

The term hematoschizotropic drugs comes from the Greek words hemato- (relating to blood) and schizonts (cells that separate by division). The term "schizotropic drugs" is also used, which has a similar meaning.

The main mechanism of action of hematoschizotropic drugs is stimulation of the growth and development of hematopoietic cells in the bone marrow. Some of them can also increase the number of platelets in the blood and improve their function. Among the most well-known hematoschizotropic agents are erythropoietin, granulocyte-colony-stimulating factor, thrombopoietin, etc.

Hematoschizotropic drugs are widely used in clinical practice to treat various diseases associated with a deficiency of hematopoietic cells. For example, erythropoietin is used to treat anemia in chronic kidney disease, and granulocyte colony-stimulating factor is used to stimulate granulocyte formation during cancer chemotherapy.

Like any medicine, hematoschizotropic drugs have side effects. Some of them may cause allergic reactions, increased blood pressure or the risk of thrombosis. Therefore, their use should be carried out under the supervision of a physician and only in cases where the benefits of treatment outweigh the possible risks.

In general, hematoschizotropic drugs are an important tool in the treatment of various diseases associated with impaired formation or functioning of hematopoietic cells. However, their use should be done with caution and only under the supervision of a physician.



Hematoschizotropic (hemato- + “schizonts” + Greek “tropos” - turn) drugs are drugs that act on schizonts (parasitic cells) in the human body. Schizonts are the main source of infection in some diseases, such as malaria, leishmaniasis, toxoplasmosis and others.

Hematoschizotropic drugs are used to treat these diseases and can have different chemical structures and mechanisms of action. Some of them act on the mitochondria of schizonts, which leads to their death. Other drugs block the production of proteins necessary for schizonts to reproduce.

One of the most well-known hematoschizotropic drugs is chloroquine, which is used to treat malaria. It acts on the mitochondrial system of schizonts and causes their death. Chloroquine is also used to prevent malaria, as it can prevent infection by schizonts.

Another example of a hematoschizotopic drug is dapsone, which is used in the treatment of leishmaniasis. It blocks the production of a protein necessary for parasitic cells to reproduce. Dapsone may also be used to prevent leishmaniasis in people who are in areas where the disease is common.

It is important to note that hematoschizotropic drugs can cause side effects such as nausea, vomiting, headache and others. Therefore, before starting treatment, you must consult your doctor and follow his recommendations.